Pedersen S - Search Results

1

Cardiotoxicity in metastatic melanoma patients treated with BRAF and MEK inhibitors in a real-world setting.

Pedersen S, Larsen KO, Christensen AH, Svane IM, Zerahn B, Ellebaek E. Pedersen S, et al. Acta Oncol. 2022 Jan;61(1):45-51. doi: 10.1080/0284186X.2021.1992010. Epub 2021 Oct 19. Acta Oncol. 2022. PMID: 34666597

2

Association of Hydrochlorothiazide Use and Risk of Malignant Melanoma.

Pottegård A, Pedersen SA, Schmidt SAJ, Hölmich LR, Friis S, Gaist D. Pottegård A, et al. Among authors: pedersen sa. JAMA Intern Med. 2018 Aug 1;178(8):1120-1122. doi: 10.1001/jamainternmed.2018.1652. JAMA Intern Med. 2018. PMID: 29813157 Free PMC article.

3

Real-world data on melanoma brain metastases and survival outcome.

Pedersen S, Møller S, Donia M, Persson GF, Svane IM, Ellebaek E. Pedersen S, et al. Melanoma Res. 2022 Jun 1;32(3):173-182. doi: 10.1097/CMR.0000000000000816. Epub 2022 Mar 7. Melanoma Res. 2022. PMID: 35256571

4

Quality of life and mental health in real-world patients with resected stage III/IV melanoma receiving adjuvant immunotherapy.

Pedersen S, Holmstroem RB, von Heymann A, Tolstrup LK, Madsen K, Petersen MA, Haslund CA, Ruhlmann CH, Schmidt H, Johansen C, Svane IM, Ellebaek E. Pedersen S, et al. Acta Oncol. 2023 Jan;62(1):62-69. doi: 10.1080/0284186X.2023.2165449. Epub 2023 Jan 16. Acta Oncol. 2023. PMID: 36645166

5

Sustained improved survival of patients with metastatic melanoma after the introduction of anti-PD-1-based therapies.

Schina A, Pedersen S, Spenning AL, Laursen OK, Pedersen C, Haslund CA, Schmidt H, Bastholt L, Svane IM, Ellebaek E, Donia M. Schina A, et al. Among authors: pedersen s, pedersen c. Eur J Cancer. 2023 Dec;195:113392. doi: 10.1016/j.ejca.2023.113392. Epub 2023 Oct 20. Eur J Cancer. 2023. PMID: 37924648 Free article.

6

Outcome of adjuvant immunotherapy in a real-world nation-wide cohort of patients with melanoma.

Holmstroem RB, Pedersen S, Jurlander R, Madsen K, Donia M, Ruhlmann CH, Schmidt H, Haslund CA, Bastholt L, Svane IM, Ellebaek E. Holmstroem RB, et al. Among authors: pedersen s. Eur J Cancer. 2024 May;202:114023. doi: 10.1016/j.ejca.2024.114023. Epub 2024 Mar 19. Eur J Cancer. 2024. PMID: 38518533 Free article.

7

Hormone replacement therapy and the risk of melanoma in post-menopausal women.

Hicks BM, Kristensen KB, Pedersen SA, Hölmich LR, Pottegård A. Hicks BM, et al. Among authors: pedersen sa. Hum Reprod. 2019 Dec 1;34(12):2418-2429. doi: 10.1093/humrep/dez222. Hum Reprod. 2019. PMID: 31803923

8

Hydrochlorothiazide use and risk for Merkel cell carcinoma and malignant adnexal skin tumors: A nationwide case-control study.

Pedersen SA, Johannesdottir Schmidt SA, Hölmich LR, Friis S, Pottegård A, Gaist D. Pedersen SA, et al. J Am Acad Dermatol. 2019 Feb;80(2):460-465.e9. doi: 10.1016/j.jaad.2018.06.014. Epub 2018 Jun 18. J Am Acad Dermatol. 2019. PMID: 29913261

9

Hydrochlorothiazide use and risk of nonmelanoma skin cancer: A nationwide case-control study from Denmark.

Pedersen SA, Gaist D, Schmidt SAJ, Hölmich LR, Friis S, Pottegård A. Pedersen SA, et al. J Am Acad Dermatol. 2018 Apr;78(4):673-681.e9. doi: 10.1016/j.jaad.2017.11.042. Epub 2017 Dec 4. J Am Acad Dermatol. 2018. PMID: 29217346 Free article.

10

No association between hydrochlorothiazide use and uveal melanoma.

Pottegård A, Pedersen SA, Cognetta A, Kristensen KB. Pottegård A, et al. Eur J Clin Pharmacol. 2020 Sep;76(9):1343-1344. doi: 10.1007/s00228-020-02908-x. Epub 2020 Jun 3. Eur J Clin Pharmacol. 2020. PMID: 32495083 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,627 results

Search Page

Filters